Ingevity CorporationNGVTNYSE
Loading
R&D Expenses Over TimeStrong
Percentile Rank85
3Y CAGR-2.1%
5Y CAGR+4.7%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-2.1%/yr
vs +9.0%/yr prior
5Y CAGR
+4.7%/yr
Recent deceleration
Acceleration
-11.1pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$28.40M+1.1%
2024$28.10M-11.6%
2023$31.80M+5.0%
2022$30.30M+15.2%
2021$26.30M+16.4%
2020$22.60M+14.7%
2019$19.70M-8.4%
2018$21.50M+8.6%
2017$19.80M+160.5%
2016$7.60M-